Waters Corp. Shares Plunge Despite Strong Q2 Results
Waters Corporation (WAT), a global leader in analytical instruments and laboratory technologies, reported better-than-expected adjusted EPS and revenue in the second quarter. However, shares plunged due to concerns over a planned acquisition.
WAT's shares have shown mixed performance over the past year, underperforming the S&P 500 Index but outperforming the Health Care Select Sector SPDR Fund. The company has a market capitalization of $21.4 billion.
Analysts expect WAT's EPS to grow steadily, forecasting a 9.5% increase to $12.99 per share in fiscal 2025 and a further 9.6% rise to $3.21 per share in Q3 2025. Long-term projections suggest EPS growth of 9.2% year-over-year to $14.18 in fiscal 2026. Despite these positive expectations, WAT's shares dropped recently due to acquisition-related concerns.
WAT has consistently exceeded Wall Street's bottom-line estimates in the last four quarters. The company has received a consensus 'Moderate Buy' rating from analysts, with an average 12-month price target of approximately $376.80. The mean price target from Wall Street analysts stands at $362.36, reflecting a moderately optimistic outlook.
WAT is expected to announce its fiscal Q3 earnings on Tuesday, Nov. 4, 2025. Despite recent share price volatility, analysts remain optimistic about the company's long-term prospects, with consistent EPS growth and positive ratings. Investors will be closely watching the upcoming earnings report for further insights into the company's performance and strategic direction.
